Log In
Print this Print this

exeporfinium chloride (XF-73)

  Manage Alerts
Collapse Summary General Information
Company Destiny Pharma Ltd.
DescriptionDicationic porphyrin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationStaphylococcus
Indication DetailsPrevent post-surgical Staphylococcus aureus infections
Regulatory Designation U.S. - Qualified Infectious Disease Program (Prevent post-surgical Staphylococcus aureus infections)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today